Carlyle to sell orthopaedic implant maker Marle to IK VII Fund

The Carlyle Group sold a majority stake in Marle International, an orthopaedic implant manufacturer, to IK VII Fund. Financial terms were not disclosed. IK Investment Partners is a European private equity firm with several previous healthcare investments.

25 May 2016•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles